On June 26th, Glonhe jumped more than 10%, and Bai Hua Cun Pharma Tech, Brightgene Bio-Medical Technology Co.,Ltd., Novotech Inc, Shengnuo Biotech, Shanghai Medicilon Inc. and Dezhan Healthcare followed the rise. In terms of news, the two giants of weight loss drugs in the US both set historical highs. Novo-nordisk a/s rose 3.25% to $146.91, and Eli Lilly and Co rose 1.63% to $904.61.
A股减肥药概念股拉升 争光股份涨超10%
Weight loss drug concept stocks in A-shares surged, and Zhengguang shares rose more than 10%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.